July 14, 2023
1 min watch
Save
VIDEO: LAMP study focuses on atropine for myopia control
NEW ORLEANS — In this Healio Video Perspective from the ARVO meeting, Mark A. Bullimore, MCOptom, PhD, FAAO, discussed the use of atropine for myopia control in the LAMP study.
“One of the challenges is that [the LAMP study] only had control data in the first year because for ethical reasons, after 1 year, the control patients were switched to a concentration of atropine,” Bullimore, of the University of Houston College of Optometry, said.
Reference:
Published by:
Sources/Disclosures
Collapse
Source:
Bullimore MA, et al. Efficacy in myopia control — Three-year predictions from the LAMP study. Presented at: Association for Research in Vision and Ophthalmology meeting; April 23-27, 2023; New Orleans.
Disclosures:
Bullimore reports consulting for Alcon Research, CooperVision, CorneaGen, EssilorLuxottica, Euclid Systems, Eyenovia, Genentech, Johnson & Johnson Vision, Lentechs, Novartis, Paragon Vision Sciences and Vyluma.
Read more about